These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 33841405)
1. Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages Zhang H; Liu M; Zhong W; Zheng Y; Li Y; Guo L; Zhang Y; Ran Y; Zhao J; Zhou L; Wang B Front Immunol; 2021; 12():624360. PubMed ID: 33841405 [TBL] [Abstract][Full Text] [Related]
2. Zhang H; Liu M; Liu X; Zhong W; Li Y; Ran Y; Guo L; Chen X; Zhao J; Wang B; Zhou L Front Immunol; 2020; 11():569104. PubMed ID: 33123141 [TBL] [Abstract][Full Text] [Related]
3. A Novel Synbiotic Alleviates Autoimmune Hepatitis by Modulating the Gut Microbiota-Liver Axis and Inhibiting the Hepatic TLR4/NF-κB/NLRP3 Signaling Pathway. Kang Y; Kuang X; Yan H; Ren P; Yang X; Liu H; Liu Q; Yang H; Kang X; Shen X; Tong M; Li L; Wang X; Guo L; Ma J; Zhang F; Fan W mSystems; 2023 Apr; 8(2):e0112722. PubMed ID: 36794950 [TBL] [Abstract][Full Text] [Related]
4. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis. Liao L; Schneider KM; Galvez EJC; Frissen M; Marschall HU; Su H; Hatting M; Wahlström A; Haybaeck J; Puchas P; Mohs A; Peng J; Bergheim I; Nier A; Hennings J; Reißing J; Zimmermann HW; Longerich T; Strowig T; Liedtke C; Cubero FJ; Trautwein C Gut; 2019 Aug; 68(8):1477-1492. PubMed ID: 30872395 [TBL] [Abstract][Full Text] [Related]
5. RIP3 blockade prevents immune-mediated hepatitis through a myeloid-derived suppressor cell dependent mechanism. Liu M; Zhang H; Zhang L; Liu X; Zhou S; Wang X; Zhong W; Zhang J; Wang B; Zhao J; Zhou L Int J Biol Sci; 2022; 18(1):199-213. PubMed ID: 34975327 [TBL] [Abstract][Full Text] [Related]
6. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis. Lin R; Zhou L; Zhang J; Wang B Int J Clin Exp Pathol; 2015; 8(5):5153-60. PubMed ID: 26191211 [TBL] [Abstract][Full Text] [Related]
7. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis. Czaja AJ World J Gastroenterol; 2016 Nov; 22(42):9257-9278. PubMed ID: 27895415 [TBL] [Abstract][Full Text] [Related]
8. [Inhibition of receptor-interacting protein 3 improves experimental autoimmune hepatitis]. Liu M; Zhang HX; Zhang L; Zhao JW; Zhou L; Wang BM Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1231-1236. PubMed ID: 36891703 [No Abstract] [Full Text] [Related]
9. Fecal Microbiota Transplantation Controls Progression of Experimental Autoimmune Hepatitis in Mice by Modulating the TFR/TFH Immune Imbalance and Intestinal Microbiota Composition. Liang M; Liwen Z; Jianguo S; Juan D; Fei D; Yin Z; Changping W; Jianping C Front Immunol; 2021; 12():728723. PubMed ID: 34912328 [TBL] [Abstract][Full Text] [Related]
10. Dextran sulfate sodium-induced gut microbiota dysbiosis aggravates liver injury in mice with S100-induced autoimmune hepatitis. Wang ZY; Gao PP; Li L; Chen TT; Li N; Qi M; Zhang SN; Xu YP; Wang YH; Zhang SH; Zhang LL; Wei W; Du M; Sun WY Immunol Lett; 2023 Nov; 263():70-77. PubMed ID: 37797724 [TBL] [Abstract][Full Text] [Related]
11. Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management. Czaja AJ Dig Dis Sci; 2018 Jul; 63(7):1706-1725. PubMed ID: 29671161 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642 [TBL] [Abstract][Full Text] [Related]
13. Gut microbiota promotes macrophage M1 polarization in hepatic sinusoidal obstruction syndrome via regulating intestinal barrier function mediated by butyrate. Zhao S; Zhang H; Zhu H; Zhao T; Tu J; Yin X; Yang S; Zhang W; Zhang F; Zhang M; Xu B; Zhuge Y; Xiao J Gut Microbes; 2024; 16(1):2377567. PubMed ID: 39012957 [TBL] [Abstract][Full Text] [Related]
14. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. Pierantonelli I; Rychlicki C; Agostinelli L; Giordano DM; Gaggini M; Fraumene C; Saponaro C; Manghina V; Sartini L; Mingarelli E; Pinto C; Buzzigoli E; Trozzi L; Giordano A; Marzioni M; Minicis S; Uzzau S; Cinti S; Gastaldelli A; Svegliati-Baroni G Sci Rep; 2017 Sep; 7(1):12200. PubMed ID: 28939830 [TBL] [Abstract][Full Text] [Related]
15. Intestinal microbiome and permeability in patients with autoimmune hepatitis. Cai W; Ran Y; Li Y; Wang B; Zhou L Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):669-673. PubMed ID: 29566910 [TBL] [Abstract][Full Text] [Related]
16. Alterations of gut microbiome in autoimmune hepatitis. Wei Y; Li Y; Yan L; Sun C; Miao Q; Wang Q; Xiao X; Lian M; Li B; Chen Y; Zhang J; Li Y; Huang B; Li Y; Cao Q; Fan Z; Chen X; Fang JY; Gershwin ME; Tang R; Ma X Gut; 2020 Mar; 69(3):569-577. PubMed ID: 31201284 [TBL] [Abstract][Full Text] [Related]
17. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction. Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899 [TBL] [Abstract][Full Text] [Related]
18. Alcoholic liver disease: the gut microbiome and liver cross talk. Hartmann P; Seebauer CT; Schnabl B Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593 [TBL] [Abstract][Full Text] [Related]
19. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Ponziani FR; Zocco MA; Cerrito L; Gasbarrini A; Pompili M Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):641-656. PubMed ID: 29806487 [TBL] [Abstract][Full Text] [Related]
20. Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability. Liu Q; Tian H; Kang Y; Tian Y; Li L; Kang X; Yang H; Wang Y; Tian J; Zhang F; Tong M; Cai H; Fan W J Nutr Biochem; 2021 Dec; 98():108863. PubMed ID: 34517094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]